The Use of Strannik Virtual Scanning as a Screening Modality for the Early Screening of Alzheimer’s Disease

This short report highlights the ability of the Strannik Virtual Scanning cognitive test to determine the pathological correlates of complex medical conditions, in particular Alzheimer’s disease. At present there are no tests which are able to determine the complex pathological correlates of Alzheimer’s disease. The results from an SVS test may contribute to a better understanding of the condition, in particular how it can be diagnosed, and how it can be treated. This paper reports the currently available data. An SVS test is able to qualitatively and quantitatively define from its presymptomatic origins the genetic and phenotypic components of the contributory pathologies which influence brain function - typically encephalopathy, degenerative problems in the spine and spinal ganglia e.g. arachnoiditis, ganglioradiculitis, impaired spinal circulation; which may be exacerbated by diabetes and diabetic comorbidities, in particular cardiac insufficiency; which conceivably influence insulin reactivity (and hence the biological availability of insulin to sustain brain function) and the flow of nutrients and oxygen to the brain. A number of case studies are presented and discussed which illustrate that SVS adopts a more advanced and cost-effective technique which is able to determine the onset and progression of Alzheimer’s disease than is currently available.